Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Frontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered…

Frontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered…
Founded: 2018
Headquarters: Boston and South San Francisco
Tech focus: Chemoproteomics, covalent chemistry, machine learning
Lead program: FMC-376 (KRAS G12C inhibitor)
Notable investors: Deerfield Management, Droia Ventures, Galapagos, DCVC Bio, MPM Capital, RA Capital
Discovering and developing small-molecule therapies against previously undruggable, disease-causing proteins (oncology focus).
2018
Biotechnology Research
67000000
Launch/Series A financing
80000000
Oversubscribed Series C with significant participation from Galapagos NV
“Backed by life-science and growth investors including Deerfield Management Company, Droia Ventures, Galapagos NV, DCVC Bio, MPM Capital, RA Capital, Deep Track Capital, ArrowMark Partners, Driehaus Capital, Sphera Global Healthcare Fund, Woodline Partners”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,400+
New This Week
| Company |
|---|